Show simple item record

dc.contributor.authorSilveira, Thêmis Res_ES
dc.contributor.authorFonseca, José Carlos daes_ES
dc.contributor.authorRivera, Luises_ES
dc.contributor.authorFay, Oscar Hes_ES
dc.contributor.authorTapia, Robertoes_ES
dc.contributor.authorSantos, José Ies_ES
dc.contributor.authorUrdeneta, Eduardoes_ES
dc.contributor.authorCosta Clemens, Sue Annes_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issued1999es_ES
dc.identifier.citationSilveira, Thêmis R,Fonseca, José Carlos da,Rivera, Luis,Fay, Oscar H,Tapia, Roberto,Santos, José I,Urdeneta, Eduardo,Costa Clemens, Sue Ann (1999) Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica;6(6) -,dic. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999001100002&lng=pt&nrm=isoes_ES
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999001100002&lng=pt&nrm=isoes_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/8884
dc.format.extentiluses_ES
dc.format.extenttabes_ES
dc.relation.ispartofseriesRev Panam Salud Publica;6(6),dic. 1999es_ES
dc.subjectHepatite Bes_ES
dc.subjectAnticorpos Anti-Hepatite Bes_ES
dc.subjectDoenças Virais Sexualmente Transmissíveispt_BR
dc.subjectTransmissão Vertical de Doença Infecciosapt_BR
dc.subjectArgentinaes_ES
dc.subjectBrasilpt_BR
dc.subjectChilees_ES
dc.subjectMexicoes_ES
dc.subjectRepública Dominicanaes_ES
dc.subjectVenezuelaes_ES
dc.titleHepatitis B seroprevalence in Latin Americaes_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesThe seroprevalence of hepatitis B was investigated in over 12.000 subjects in six countries of Latin America: Argentina, Brazil, Chile, the Dominican Republic, Mexico and Venezuela. Each study population was stratified according to age, gender and socioeconomic status. Antibodies against hepatitis B core antigen (anti-HBc) were measured in order to determine hepatitis B infection. The highest overall seroprevalence was found in the Dominican Republic (21.4 por ciento), followed by Brazil (7,9 por ciento), Venezuela (3,2 por ciento), Argentina (2,1 por ciento), Mexico (1,4 por ciento) and Chile (0,6 por ciento). In all the countries an increase in seroprevalence was found among persons 16 years old and older, suggesting sexual transmission as the major route of infection. In addition, comparatively high seroprevalence levels were seen at an early age in the Dominican Republic and Brazil, implicating a vertical route of transmissionen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record